What is leukemia? – Danilo Allegra and Dania Puggioni View full lesson: http://ed.ted.com/lessons/what-is-leukemia-danilo-allegra-and-dania-puggioni Stem cells found in the bone marrow are crucial for our health because they are needed to become new blood cells that sustain and protect our bodies. But when the transformation goes wrong, harmful mutations can cause the cells to start replicating […]

What is the Survival Rate for Multiple Myeloma?

Multiple Myeloma simplified | Speedy medical Hematology lectures | Usmle | W.B.C disorders | Multiple myeloma (MM), also known as plasma cell myeloma and simple myeloma, is a cancer of plasma cells, a type of white blood cell that normally produces antibodies. Often, no symptoms are noticed initially. As it progresses, bone pain, bleeding, frequent […]

What is the Difference Between Primary Plasma Cell Leukemia and Secondary Plasma Cell Leukemia? What is the difference between primary and secondary of plasma cell leukemia? Primary PCL is where the patient is present with circulating plasma cells. HealthTree University, provided by the Myeloma Crowd, offers a comprehensive online multiple myeloma curriculum with lessons, quizzes […]

The role of PET/CT in multiple myeloma Jakob Nordberg Nørgaard, PhD, Oslo University Hospital, Oslo, Norway, outlines the role of PET/CT in the diagnosis and management of multiple myeloma. PET/CT is a very sensitive technique used for the diagnosis of extramedullary disease and osteolytic lesions, as well as for risk stratification and response assessment. This […]

MRD updates in multiple myeloma at ASH 2021 Faith Davies, MBBCh, MRCP, MD, FRCPath, NYU Langone Medical Center, New York, NY, provides updates in the field of minimal residual disease (MRD) testing in multiple myeloma, including studies assessing the MRD status of patients receiving daratumumab at different points in time, as well as data linking […]

CyborD-DARA combination in first-line treatment for multiple myeloma Michael O’Dwyer, MD, PhD, from the National University of Ireland, Galway, Ireland, discusses the advantages of bringing daratumumab in the first-line setting as the CyborD-DARA combination ( cyclophosphamide, bortezomib and dexamethasone with daratumumab), for the treatment of multiple myeloma. Here, Prof. O’ Dwyer highlights that cyclophosphamide can […]

Multiple Myeloma: Stem Cell Transplant and Beyond 2021 Summary: Learn when patients with myeloma should consider transplant, steps involved in transplant, maintenance therapy options after transplant, and new therapies to manage multiple myeloma. Multiple myeloma is the most common cancer of the bone marrow. This presentation discusses transplant options and drug therapies for treating myeloma. […]

What Are The Stages Of Multiple Myeloma? Multiple myeloma is a cancer of plasma cells, which are a typically located in the bone marrow. The bone marrow is the soft, sponge-like tissue in the center of most bones. Dr. Cesar Rodriguez Valdes discusses what you need to know about multiple myeloma, including how it is […]

Screening programs for plasma cell disorders Irene Ghobrial, MD, of the Dana-Farber Cancer Institute, Boston, MA, and Maria-Victoria Mateos, MD, PhD, of the University of Salamanca, Salamanca, Spain, discuss the importance of screening and explain how a screening programme for early stages of myeloma could significantly improve survival outcomes for patients. Dr Ghobrial talks on […]